Erli Gao

899 Pinghai Street
Suzhou, 215006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

FASN inhibits ferroptosis in breast cancer via USP5 palmitoylation-dependent regulation of GPX4 deubiquitination.

FASN inhibits ferroptosis in breast cancer via USP5 palmitoylation-dependent regulation of GPX4 deubiquitination.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 07, 2025

SEL1L confers reduced EMT and drug resistance to breast cancer cells by promoting Shh degradation.

SEL1L confers reduced EMT and drug resistance to breast cancer cells by promoting Shh degradation.

Journal: iScience

Published: February 10, 2025

High GOLT1A expression induces poor prognosis in papillary thyroid carcinoma.

High GOLT1A expression induces poor prognosis in papillary thyroid carcinoma.

Journal: Scientific reports

Published: February 08, 2025

Comprehensive analysis of PTPN gene family revealing PTPN7 as a novel biomarker for immuno-hot tumors in breast cancer.

Comprehensive analysis of PTPN gene family revealing PTPN7 as a novel biomarker for immuno-hot tumors in breast cancer.

Journal: Frontiers in genetics

Published: June 29, 2022

Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer.

Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer.

Journal: Journal of oncology

Published: April 29, 2022

Systematic Characterization of Expression Patterns and Immunocorrelations of Formin-Like Genes in Breast Cancer.

Systematic Characterization of Expression Patterns and Immunocorrelations of Formin-Like Genes in Breast Cancer.

Journal: BioMed research international

Published: March 28, 2022

Prognostic value of the systemic inflammation response index (SIRI) before and after surgery in operable breast cancer patients.

Prognostic value of the systemic inflammation response index (SIRI) before and after surgery in operable breast cancer patients.

Journal: Cancer biomarkers : section A of Disease markers

Published: June 23, 2020

Effectiveness of OK-432 (Sapylin) to reduce seroma formation after axillary lymphadenectomy for breast cancer.

Effectiveness of OK-432 (Sapylin) to reduce seroma formation after axillary lymphadenectomy for breast cancer.

Journal: Annals of surgical oncology

Published: July 02, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026